Safety Study of Live Attenuated Influenza Vaccine, CodaVax
Condition:   Influenza Interventions:   Biological: CodaVax-H1N1;   Biological: Fluzone quadrivalent;   Biological: Placebo Sponsor:   Codagenix, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2019 Category: Research Source Type: clinical trials

Safety Study of Live Attenuated Influenza Vaccine, CodaVax
Condition:   Influenza Interventions:   Biological: CodaVax-H1N1;   Biological: Fluzone quadrivalent Sponsor:   Codagenix, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2019 Category: Research Source Type: clinical trials

Safety Study of Live Attenuated Influenza Vaccine, CodaVax
Condition:   Influenza Interventions:   Biological: CodaVax-H1N1;   Biological: Fluzone quadrivalent;   Biological: Placebo Sponsor:   Codagenix, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2019 Category: Research Source Type: clinical trials

Safety Study of Live Attenuated Influenza Vaccine, CodaVax
Condition:   Influenza Interventions:   Biological: CodaVax-H1N1;   Biological: Fluzone quadrivalent Sponsor:   Codagenix, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2019 Category: Research Source Type: clinical trials

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
Conditions:   Influenza;   Influenza, Human;   Vaccine Reaction;   Influenza A;   Influenza Type B;   Influenza A H1N1;   Influenza A H3N2 Intervention:   Biological: Influenza Vaccine Recipients Sponsors:   Vanderbilt University Medical Center;   Human Vaccines Project Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2018 Category: Research Source Type: clinical trials